Quick Answer
Keros Therapeutics, Inc. reported Net Income of $87.01 million for fiscal year 2025.
Keros Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $87.01M | +146.4% |
| 2024 | -$187.35M | -22.5% |
| 2023 | -$152.99M | -46.2% |
| 2022 | -$104.68M | -78.2% |
| 2021 | -$58.74M | -29.5% |
| 2020 | -$45.36M | -267.7% |
| 2019 | -$12.34M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.28M | +86.3% | +76.3% |
| June 30, 2025 | -$30.70M | +32.2% | -120.7% |
| March 31, 2025 | $148.45M | +444.3% | +380.3% |
| September 30, 2024 | -$52.96M | -34.3% | -17.0% |
| June 30, 2024 | -$45.26M | -20.7% | -5.0% |
| March 31, 2024 | -$43.11M | -20.4% | -9.3% |
| September 30, 2023 | -$39.44M | -67.8% | -5.2% |
| June 30, 2023 | -$37.51M | -37.6% | -4.8% |
- Keros Therapeutics, Inc. showed an increase of +146.4% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Keros Therapeutics, Inc.’s net income has grown by 805.4% (from -$12.34 million to $87.01 million).
- The most recent figure is from Keros Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: